Power Law company profile

Vera Therapeutics

Biotech & Life Sciences · Brisbane, United States · Founded 2016 · IPO 2021 Unicorn

A clinical-stage biotechnology company focused on transforming patients’ lives by developing and commercializing treatments for immunological and inflammatory diseases

Valuation

$1.91B

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

9 investors on Vera Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 9 investors entered at this stage

Sofinnova Investments

Alexandria Venture Investments

Longitude Capital

Citadel

Abingworth

Fidelity Investments

Kleiner Perkins

Octagon Capital Partners

Global footprint

Where Vera Therapeutics has talent and traffic

Workforce by country

🇺🇸 United States · Brisbane HQ

Book a demo for the full country breakdown

Web traffic by country

12K monthly visits
across markets

🇺🇸 United States75%

🇬🇧 United Kingdom11.7%

🇮🇳 India11.7%

Top 3 markets shown

Market sentiment

What the market is saying about Vera Therapeutics

An AI-synthesized read of the highest-engagement posts about Vera Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vera Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles